HSPB1 and hepatocellular carcinoma: Moreover, engineered exosomes carrying miR‐654‐5p have been shown to induce ferroptosis in HCC cells by inhibiting HSPB1, enhancing the efficacy of sorafenib, a drug that is often hindered by resistance due to HSPB1 overexpression [147].